Anti-inflammatory drugs or stem cell therapy can block the transcription of BACE1 as well as the production of Aβ, suggesting that the inhibition of NF-κB-mediated BACE1 expression is the plausible target of AD treatment [87]. The gene discussed is BACE1; the disease is Alzheimer disease.